[1]
Dmitriev, A.V.; Lagunin, A.A.; Karasev, D.A.; Rudik, A.V.; Pogodin, P.V.; Filimonov, D.A.; Poroikov, V.V. Prediction of drug-drug interactions related to inhibition or induction of drug-metabolizing enzymes. Curr. Top. Med. Chem., 2019, 19(5), 319-336.
[PMID: 30674264]
[PMID: 30674264]
[2]
Saxena, A.K.; Singh, A. Mycobacterial tuberculosis enzyme targets and their inhibitors. Curr. Top. Med. Chem, 2019, 19(5), 337-355.
[3]
Tratrat, C.; Haroun, M.; Xenikakis, I.; Liaras, K.; Tsolaki, E.; Eleftheriou, P.; Petrou, A.; Aldhubiab, B.; Attimarad, M.; Venugopala, K.N.; Harsha, S.;
Elsewedy, H.S.; Geronikaki, A. Soković, M. Design, synthesis, evaluation of antimicrobial activity and docking studies of new thiazole-based chalcones. Curr. Top. Med. Chem, 2019, 19(5), 356-375.
[4]
Jangra, S.; Purushothaman, G.; Juvale, K.; Ravi, S.; Menon, A.; Kirubakaran, S.; Thiruvenkatam, V. Synthesis and in vitro enzymatic studies of new
3-aryldiazenyl indoles as promising Helicobacter pylori IMPDH inhibitors. Curr. Top. Med. Chem., 2019, 19(5), 376-382.
[PMID: 30827248]
[PMID: 30827248]
[5]
Eleftheriou, P.; Therianou, E.; Lazari, D.; Dirnali, S.; Micha, A. Docking assisted prediction and biological evaluation of sideritis l. components with
PTP1B inhibitory action and probable anti-diabetic properties. Curr. Top. Med. Chem, 2019, 19(5), 383-392.
[PMID: 30806317]
[PMID: 30806317]
Current Topics in Medicinal Chemistry
Title:Trends in Enzyme Inhibition and Activation in Drug Design - Part II
Volume: 19 Issue: 5
Author(s): Athina Geronikaki
Affiliation:
Export Options
About this article
Cite this article as:
Geronikaki Athina , Trends in Enzyme Inhibition and Activation in Drug Design - Part II, Current Topics in Medicinal Chemistry 2019; 19 (5) . https://dx.doi.org/10.2174/156802661905190418152713
DOI https://dx.doi.org/10.2174/156802661905190418152713 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
28
4
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Do we Need a New Procedure for the Assessment of Adverse Events in Anti-migraine Clinical Trials?
Recent Patents on CNS Drug Discovery (Discontinued) Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Anti-Cancer Agents in Medicinal Chemistry Decreased Expression of Caveolin-1 and E-Cadherin Correlates with the Clinicopathologic Features of Gastric Cancer and the EMT Process
Recent Patents on Anti-Cancer Drug Discovery Growth Inhibition of Human Non-Small Lung Cancer Cells H460 By Green Tea and Ginger Polyphenols
Anti-Cancer Agents in Medicinal Chemistry Autophagy and Ubiquitination as Two Major Players in Colorectal Cancer: A Review on Recent Patents
Recent Patents on Anti-Cancer Drug Discovery The Ambidextrous Cyclooxygenase: An Enduring Target
Inflammation & Allergy - Drug Targets (Discontinued) Life Under Stress: The Probiotic Stress Response and How it may be Manipulated
Current Pharmaceutical Design Recent Developments in Patents Targeting Toll-Like Receptor Genes
Recent Patents on DNA & Gene Sequences Chaperonopathies and Chaperonotherapy. Hsp60 as Therapeutic Target in Cancer: Potential Benefits and Risks
Current Pharmaceutical Design Metal Complexes of Natural Product Like-compounds with Antitumor Activity
Anti-Cancer Agents in Medicinal Chemistry DNA Repair Inhibitors: The Next Major Step to Improve Cancer Therapy
Current Topics in Medicinal Chemistry Induction of Oral Tolerance with Transgenic Plants Expressing Antigens for Prevention/Treatment of Autoimmune, Allergic and Inflammatory Diseases
Current Pharmaceutical Biotechnology Development of Molecular Targeted Anticancer Agents: Successes, Failures and Future Directions
Current Pharmaceutical Design A New Series of Antileukemic Agents: Design, Synthesis, <i>In Vitro</i> and <i>In Silico</i> Evaluation of Thiazole-Based ABL1 Kinase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Platinum-Based Agents for Individualized Cancer Treatment
Current Molecular Medicine Particulate Systems as Adjuvants and Carriers for Peptide and Protein Antigens
Current Drug Delivery Moderate Hypothermia in the Management of Severe Traumatic Brain Injury: A Good Idea Proved Ineffective?
Current Pharmaceutical Design Dual Function of Nitric Oxide in Carcinogenesis, Reappraisal
Current Drug Metabolism Exploring New CGRP Family Peptides and their Receptors in Vertebrates
Current Protein & Peptide Science Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia
Current Pharmacogenomics